Pharmadrug Inc.
PHRX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.80K | 52.00K | -132.70K | -105.20K | -368.60K |
| Total Depreciation and Amortization | 8.80K | 9.00K | 9.20K | 9.20K | 9.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.10K | -40.50K | 91.30K | 94.60K | 35.80K |
| Change in Net Operating Assets | 25.60K | -19.50K | 25.30K | -148.10K | -79.80K |
| Cash from Operations | -10.40K | 1.00K | -7.00K | -149.60K | -403.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -8.60K | -- | -- | -- |
| Cash from Investing | -- | -8.60K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 326.00K |
| Repurchase of Common Stock | -- | -91.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 87.20K | -- | -- | -- |
| Cash from Financing | -- | -3.20K | -- | -- | 241.80K |
| Foreign Exchange rate Adjustments | -- | -1.70K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.40K | -12.40K | -7.00K | -149.60K | -161.50K |